Literature DB >> 20079992

Correlation between myocardial fibrosis and the occurrence of atrial fibrillation in hypertrophic cardiomyopathy: a cardiac magnetic resonance imaging study.

S Pujadas1, R Vidal-Perez, A Hidalgo, R Leta, F Carreras, A Barros, A Bayes-Genis, M T Subirana, Guillem Pons-Llado.   

Abstract

Cardiac magnetic resonance imaging (CMR) in hypertrophic cardiomyopathy (HCM) often shows delayed contrast enhancement (DE) representing regions of focal myocardial fibrosis. Atrial fibrillation (AF) is a commonly reported complication of HCM. We determined the relationship between the presence of left ventricular myocardial fibrosis (LVMF) detected by DE-CMR and the occurrence AF in a series of patients with HCM. 67 patients with HCM (47 males; mean age 50.1+/-18.5 years) were studied by CMR measuring mass of LVMF, left ventricular mass, volume and function, and left atrial (LA) area. AF was present in 17 (25%) patients. LVMF was observed in 57% of patients. AF was significantly more frequent in patients who also showed LVMF, compared with the group without LVMF (42.1% vs. 3.4%, respectively; p<0.0001). LA size was larger in patients showing DE (LA area: 37.4+/-11.1 vs. 25.9+/-6.8 cm(2); respectively, p=0.0001). AF in HCM is related with myocardial fibrosis detected by DE-CMR and dilatation of the LA. This fact adds to the proven adverse prognostic value of myocardial fibrosis in HCM, thus, reinforcing the usefulness of this technique in the assessment of these patients. Copyright (c) 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20079992     DOI: 10.1016/j.ejrad.2009.12.012

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  10 in total

Review 1.  The role of cardiac magnetic resonance imaging in the assessment of non-ischemic cardiomyopathy.

Authors:  Mouaz H Al-Mallah; Mohammad Naseem Shareef
Journal:  Heart Fail Rev       Date:  2011-07       Impact factor: 4.214

2.  Macrocyclic contrast agents for magnetic resonance imaging of chronic myocardial infarction: intraindividual comparison of gadobutrol and gadoterate meglumine.

Authors:  Moritz Wagner; Rene Schilling; Patrick Doeblin; Alexander Huppertz; Reny Luhur; Carsten Schwenke; Martin Maurer; Bernd Hamm; Matthias Taupitz; Tahir Durmus
Journal:  Eur Radiol       Date:  2012-07-08       Impact factor: 5.315

3.  The incidence, pattern, and prognostic value of left ventricular myocardial scar by late gadolinium enhancement in patients with atrial fibrillation .

Authors:  Tomas G Neilan; Ravi V Shah; Siddique A Abbasi; Hoshang Farhad; John D Groarke; John A Dodson; Otavio Coelho-Filho; Ciaran J McMullan; Bobak Heydari; Gregory F Michaud; Roy M John; Rob van der Geest; Michael L Steigner; Ron Blankstein; Michael Jerosch-Herold; Raymond Y Kwong
Journal:  J Am Coll Cardiol       Date:  2013-08-28       Impact factor: 24.094

Review 4.  A primer on arrhythmias in patients with hypertrophic cardiomyopathy.

Authors:  Katy E Bockstall; Mark S Link
Journal:  Curr Cardiol Rep       Date:  2012-10       Impact factor: 2.931

5.  Prevalence and Impact of Atrial Fibrillation in a Cohort of Patients with Hypertrophic Cardiomyopathy in Ireland.

Authors:  McClelland S; O'Connor Sa; Donohue S; Lavelle L; McErlean A; Dodd Jd; Meaney J; McCreery Cj; McDonald K; Quinn M; Erwin Je; Quigley Pj; Maurer B; Keane D
Journal:  J Atr Fibrillation       Date:  2020-10-31

6.  Modulation of Human Cardiac TRPM7 Current by Extracellular Acidic pH Depends upon Extracellular Concentrations of Divalent Cations.

Authors:  Regina Mačianskienė; Mantė Almanaitytė; Aistė Jekabsone; Kanigula Mubagwa
Journal:  PLoS One       Date:  2017-01-27       Impact factor: 3.240

7.  Machine Learning Methods for Identifying Atrial Fibrillation Cases and Their Predictors in Patients With Hypertrophic Cardiomyopathy: The HCM-AF-Risk Model.

Authors:  Moumita Bhattacharya; Dai-Yin Lu; Ioannis Ventoulis; Gabriela V Greenland; Hulya Yalcin; Yufan Guan; Joseph E Marine; Jeffrey E Olgin; Stefan L Zimmerman; Theodore P Abraham; M Roselle Abraham; Hagit Shatkay
Journal:  CJC Open       Date:  2021-02-02

8.  Single-dose gadobutrol in comparison with single-dose gadobenate dimeglumine for magnetic resonance imaging of chronic myocardial infarction at 3 T.

Authors:  Moritz Wildgruber; Thomas Stadlbauer; Michael Rasper; Alexander Hapfelmeier; Otto Zelger; Hans-Henning Eckstein; Martin Halle; Ernst J Rummeny; Armin M Huber
Journal:  Invest Radiol       Date:  2014-11       Impact factor: 6.016

9.  Prognostic and functional implications of left atrial late gadolinium enhancement cardiovascular magnetic resonance.

Authors:  Michael Quail; Karl Grunseich; Lauren A Baldassarre; Hamid Mojibian; Mark A Marieb; Daniel Cornfeld; Aaron Soufer; Albert J Sinusas; Dana C Peters
Journal:  J Cardiovasc Magn Reson       Date:  2019-01-03       Impact factor: 5.364

10.  Atrial matrix remodeling in atrial fibrillation patients with aortic stenosis.

Authors:  Mariana Fragão-Marques; I Miranda; D Martins; I Barroso; C Mendes; A Pereira-Neves; I Falcão-Pires; A Leite-Moreira
Journal:  BMC Cardiovasc Disord       Date:  2020-10-31       Impact factor: 2.298

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.